期刊文献+

复方乙肝解毒丸抗DHBV的研究Ⅱ.治疗效果及病理形态观察 被引量:1

Experimental Research of the Compound Hepatitis B Antidotic Pellet against DHBV Ⅱ.Experimental Effect and Observation of Pathologic Picture
下载PDF
导出
摘要 用DHBV阳性血清经腹腔感染雏鸭后,药物试验组与对照组DHBV感染率分别为67.61%、65.52%。经复方乙肝解毒丸治疗2个月后,采集血清作DHBV-DNA斑点杂交试验。结果,药物试验组与对照组转阴率分别为34.04%、7.89%。两组有显著差异。鸭乙肝病毒与人乙肝病毒同属嗜肝DNA病毒,本实验结果为临床治疗乙肝患者提供了可靠依据。 Abstract The DHBV infective rateS of the experimental group and control group were 67.61% and 65.52% reSpectively in young ducks after infected with the positive serum of DHBV by dominal cavities.W6 found that the transformation rates from POSitive to negative in experimental group and control group were 34.04% and 7.89% respectively',detected by spot hybridization of DHBV to sera of younger ducks having been treated with the compound hepatitis B antidotic Pellet for two months.There was a significant diffrence between the tWo groups(P<0.01).These xeperimental results provided rgliable evidenCed for treating P8tients with hepatitis B clinically because the duck virus and HBV of Humanbeings all belong to liver-ophilic DNA virus.
出处 《中国畜禽传染病》 CSCD 1995年第1期6-8,共3页
基金 省中医局课题
  • 相关文献

参考文献1

  • 1顾健人,陈莹,徐来,陈渊卿,钱耕荪,瞿永华,郁云皎,蒋惠秋.从启东鸭肝癌中分离和克隆出人乙肝病毒样的DNA序列[J]肿瘤,1988(05).

同被引文献18

  • 1周翊钟 寇平原.一种可能与鸭肝炎和肝癌相关的病毒[J].上海医学,1980,3:1-3.
  • 2Yokosuka O, Omata M, lmazeki F, et al. Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology, 1985, 5:728-734.
  • 3Nevens F, Main J, Honkoop P, et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.Gastroenterology, 1997, 113 : 1258-1263.
  • 4Lai CL, Chien RN, Leung NW et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med, 1998, 339:61-68.
  • 5Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Hepatology, 1998, 27 : 1670-1677.
  • 6Fu L, Cheng YC. Role of additional mutations outside the YMDD motif of hepatitis B virus polymerase in L(-)SddC(3TC)resistance. Biochem Pharmacol, 1998, 55:1567-1572.
  • 7Wright TL, Lau JY. Clinical aspects of hepatitis B virus infection. Lancet, 1993, 342:1340-1344.
  • 8Lai CL, Chien RN, Leung NW, et al. A 1-year trial of lamivudine for chronic hepatitis B. N Engl J Med, 1998, 339:61-68.
  • 9Jilbert AR, Freiman JS, Gowans El, et al. Duck hepatitis B virus DNA in liver, spleen, and pancreas: analysis by in situ and Southern blot hybridization. Virology, 1987, 158:330-338.
  • 10Jilbert AR, Wu TT, England JM, et al. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol, 1992, 66:1377-1388.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部